Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib was effective in treating both early and late onset alopecia areata.

Using Janus kinase inhibitors (JAKi) in COVID-19 treatment requires careful consideration due to their immunosuppressive effects.

Baricitinib helps regrow hair in teens with severe alopecia areata.

Combining fractionated CO2 laser with tacrolimus may help treat chronic alopecia areata.

Upadacitinib significantly improved both rheumatoid arthritis and alopecia areata in a patient.

Ritlecitinib is effective and safe for long-term treatment of alopecia areata.

Tofacitinib effectively regrows hair in alopecia areata patients, especially in younger individuals, with manageable side effects.

The ointment effectively treats neurodermatitis and chronic eczema without causing skin irritation.

Ritlecitinib effectively improves hair regrowth and physician satisfaction in severe alopecia areata over time.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

Ritlecitinib is effective and safe for hair regrowth in Asian patients with alopecia areata.

A balanced approach using dutasteride and Serenoa repens can improve hair transplant success by protecting follicles and minimizing side effects.

Topical tacrolimus can effectively treat erosive pustular dermatosis and related hair loss.

Low-dose oral minoxidil may be effective for hair loss treatment.

The drug enzalutamide may reduce the ability of the virus causing COVID-19 to enter lung cells.

Ritlecitinib is effective for long-term treatment of severe alopecia areata.

Methotrexate plus prednisolone had the fewest serious side effects.

Oral baricitinib is effective and safe for treating alopecia areata.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

JAK inhibitors effectively regrow hair in alopecia areata but hair loss often returns after stopping treatment.

The treatment with Shunyou and prednisone is effective and safe for lupus nephritis.

Combining pulsed prednisone with tofacitinib can lead to lasting hair regrowth in severe alopecia areata patients.

These new skin treatments are safer and more effective with minimal side effects.

Clobetasol propionate 0.05% is more effective for hair re-growth in alopecia areata than tacrolimus 0.1%.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.

Ritlecitinib effectively promotes hair regrowth in severe and very severe alopecia areata.

Baricitinib is more effective than methotrexate for severe alopecia areata.